Q4 Earnings Update

Biocon Q4 Results: Cons PAT grows 31% YoY to Rs 313 crore, revenue surges 57%

by
Biocon Q4 Results: Cons PAT grows 31% YoY to Rs 313 crore, revenue surges 57%

MUMBAI – Pharmaceutical major Biocon today reported a 31.3% year-on-year (YoY) rise in consolidated net profit for the March quarter to Rs 313 crore on the back of a strong revenue growth. Consolidated revenue from operations increased 57% on year to Rs 3,774 crore. The board has recommended a final dividend payout of Rs 1.50 … Read more

Q4 earnings, US GDP data & FII flows among 6 key drivers for Dalal Street this week

by
Q4 earnings, US GDP data & FII flows among 6 key drivers for Dalal Street this week

Amid weak global cues and cautious March quarters earnings, Indian equity indices remained in the red last week. However, on Friday, Reliance Industries and ICICI Bank results matched the expectation of the analysts. The BSE Sensex index ended 847 points or 1.40% lower at 59,538, while Nifty50 fell 204 points or 1.14% at 18,828 last … Read more